Advertisement

Picture EBD Group Biotech Showcase 2023 San Francisco 650x100px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 4947 | Ordered by Date (descending)
1 2 3 ... 48 49 50  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Catalym–Bavaria (govt): investment, 202211 financing round Series C totalling €50m incl existing + co-investor Bayern Kapital 2022-11-22
Catalym–BioGeneration Ventures: investment, 202211 financing round Series C totalling €50m incl existing + co-investor BGV 2022-11-22
Catalym–Brandon Capital: investment, 202211 financing round Series C totalling €50m incl new + co-lead investor Brandon Capital 2022-11-22
Catalym–Forbion: investment, 202211 financing round Series C totalling €50m incl existing + co-investor Forbion 2022-11-22
Catalym–Germany (govt): investment, 202211 financing round Series C totalling €50m incl existing + co-investor Coparion 2022-11-22
Catalym–Jeito Capital: investment, 202211 financing round Series C totalling €50m incl new + co-lead investor Jeito Capital 2022-11-22
Catalym–Novartis: investment, 202211 financing round Series C totalling €50m incl existing + co-investor Novartis Venture Fund 2022-11-22
Catalym–SEVERAL: investment, 202211 financing round Series C €50m led by Brandon Capital + Jeito Capital 2022-11-22
Catalym–Trophic Communications: public relations, 202211 service existent by Trophic 2022-11-22
Catalym–Vesalius Biocapital: investment, 202211 financing round Series C totalling €50m incl existing + co-investor Vesalius Biocapital III 2022-11-22
FogPharma–HBM: investment, 202211 financing round Series D totalling $178m incl existing investor HBM Healthcare Investments 2022-11-21
FogPharma–SEVERAL: investment, 202211 financing round Series D $178m from existing + new investors 2022-11-21
Cradle Bio–Index Ventures: investment, 202211 seed financing round totalling €5.5m incl co-lead investor Index Ventures 2022-11-17
Cradle Bio–Kindred Capital: investment, 202211 seed financing round totalling €5.5m incl co-lead investor Kindred Capital 2022-11-17
Cradle Bio–PERSON: investment, 202211 seed financing round totalling €5.5m incl angel investor Emily LeProust 2022-11-17
Cradle Bio–PERSON: investment, 202211 seed financing round totalling €5.5m incl angel investor Feike Sijbesma 2022-11-17
Cradle Bio–PERSON: investment, 202211 seed financing round totalling €5.5m incl angel investor Sylvain Gariel 2022-11-17
Cradle Bio–SEVERAL: investment, 202211 emerges from stealth with €5.5m seed financing round led by Index Ventures + Kindred Capital 2022-11-17
Sarcura–SEVERAL: investment, 202211 seed plus financing round €7m co-led by Lansdowne Investment Co Cyprus + IST Cube 2022-11-17
Novigenix–SEVERAL: investment, 202211 financing round Series B first closing €? of €20m from existing + new investors 2022-11-16
Roche–Jnana Therapeutics: small-molecule drug discovery, 202211– collab + license $50m upfront + >2b milestones RAPID platform for multiple targets 2022-11-15
Neurescence–Bruker: investment, 202211 acquisition 100% of Neurescence Inc by Bruker 2022-11-14
BC Platforms–Jolt Capital: investment, 202211 growth financing round totalling CHF20m incl new + lead investor Jolt Capital 2022-11-08
BC Platforms–SEVERAL: investment, 202211 growth financing round CHF20m led by new investor Jolt Capital 2022-11-08
Inscopix–Bruker: investment, 202211 acquisition €na of Inscopix by Bruker 2022-11-08
Ayoxxa–NONE: investment, 202211– filed for bankruptcy 2022-11-04
Centogene–BC Platforms: data integration and analysis s/w, 202211– collab Centogene launches Biodata Network on BCRQUEST.com of BC Platforms 2022-11-03
Ono Pharmaceutical–Memo Therapeutics: antibody drug discovery, 202211– collab r+d antibodies for immuno-oncology targets 2022-11-01
Tamer Group–CellPhenomics: Reverse Clinical Engineering, 202211– collab sale of RCE of ASC Oncology by Tamer Group in MENA region 2022-11-01
Binding Site–Thermo Fisher: investment, 202210– acquisition £2.25b in cash from shareholder group led by Nordic Capital ANNOUNCED 2022-10-31
Cyclarity Therapeutics–Forever Healthy: investment, 202210 existent investor Kizoo Technology Capital 2022-10-26
MoglingBio–Forever Healthy: investment, 202210 seed financing with sole investor Kizoo Technology Capital 2022-10-26
Alto Neuroscience–SEVERAL: investment, 202210 financing round Series B $35m led by Lightswitch Capital + Alkeon Capital 2022-10-25
Evotec–MHH: biospecimen, 202210– collab access to SjS + SLE patient biospecimen for analysis with PanOmics platform to expand E.MPD database 2022-10-25
European Spatial Biology Center–Resolve Biosciences: Molecular Cartography technology, 202210 supply to ESBC existent 2022-10-24
Helmholtz–Resolve Biosciences: Molecular Cartography technology, 202210 supply to DKFZ existent as one of first customers 2022-10-24
Resolve Biosciences–Alafi Capital: investment, 202210 financing round Series B totalling $71m incl existing + co-investor Alafi Capital 2022-10-24
Resolve Biosciences–EDBI: investment, 202210 financing round Series B totalling $71m incl co-investor EDBI 2022-10-24
Resolve Biosciences–North Rhine-Westphalia (govt): investment, 202210 financing round Series B totalling $71m incl co-investor NRW.BANK 2022-10-24
Resolve Biosciences–Patient Square Capital: investment, 202210 financing round Series B totalling $71m incl lead investor Patient Square Capital 2022-10-24
Resolve Biosciences–PS Capital Management: investment, 202210 financing round Series B totalling $71m incl existing + co-investor PS Capital 2022-10-24
Resolve Biosciences–SEVERAL: investment, 202210 financing round Series B $71m led by Patient Square Capital 2022-10-24
Stanford Univ–Resolve Biosciences: Molecular Cartography technology, 202210 supply to Stanford Medicine Dept of Genetics existent 2022-10-24
Univ Copenhagen–Resolve Biosciences: Molecular Cartography technology, 202210 supply to Novo Nordisk Foundation Center existent 2022-10-24
VIB–Resolve Biosciences: Molecular Cartography technology, 202210 supply to VIB existent as one of first customers 2022-10-24
HMNC–SEVERAL: investment, 202210 financing round 1st closing €14.3m from new + existing investors 2022-10-20
Nucleome Therapeutics–Merck (DE): investment, 202210 financing round Series A totalling £37.5m incl new + lead investor M Ventures 2022-10-19
Nucleome Therapeutics–SEVERAL: investment, 202210 financing round Series A £37.5m led by M Ventures 2022-10-19
Anokion–Pfizer: investment, 202210 equity investment $35m through Pfizer Breakthrough Growth Initiative 2022-10-18
PBD Biotech–Foresight Group: investment, 202210 follow-on financing round totalling £2.4m incl co-lead investor Foresite Group via MEI Fund 2022-10-17
PBD Biotech–Mercia: investment, 202210 follow-on financing round totalling £2.4m incl co-lead investor Mercia via MEI Fund 2022-10-17
PBD Biotech–OTHER: investment, 202210 follow-on financing round totalling £2.4m incl private investors as co-investors 2022-10-17
PBD Biotech–SEVERAL: investment, 202210 follow-on financing round £2.4m co-led by Mercia + Foresight Group 2022-10-17
PBD Biotech–Univ Nottingham: investment, 202210 follow-on financing round totalling £2.4m incl co-investor Univ of Nottingham 2022-10-17
Bavaria (govt)–Osaka (govt): life sciences, 202210– collab third renewal of partnership of BioM + Osaka Bio Headquarters originally signed in 2011 2022-10-12
Apollo Health Ventures–Trophic Communications: public relations, 202210 service existent by Trophic 2022-10-11
Focal Biosciences–Apollo Health Ventures: investment, 202210 founding investor Apollo HV launches Focal Biosciences with Paul Scherrer Institute 2022-10-11
Andera Partners–SEVERAL: investment, 202210 final closing of BioDiscovery 6 fund at €456m 2022-10-10
Immatics–SEVERAL: investment, 202210 underwritten offering $110m with 10.9m ordinary shares at $10.09/share 2022-10-10
Cevec–Danaher: investment, 202210 acquisition of Cevec by Cytiva 2022-10-06
Irubis–EU (govt): investment, 202210 seed financing round totalling €2.8m incl co-investor EIC Fund 2022-10-06
Irubis–High-Tech Gründerfonds: investment, 202210 seed financing round totalling €2.8m incl co-lead investor HTGF 2022-10-06
Irubis–OTHER: investment, 202210 seed financing round totalling €2.8m incl business angels as co-investors 2022-10-06
Irubis–SEVERAL: investment, 202210 seed financing round €2.8m led by HTGF + Verve Ventures + Ventura BioMed Investors 2022-10-06
Irubis–TU Munich: investment, 202210 seed financing round totalling €2.8m incl co-investor Initiative for Industrial Innovators 2022-10-06
Irubis–Ventura Biomed Investors: investment, 202210 seed financing round totalling €2.8m incl co-lead investor Ventura Biomed Investors 2022-10-06
Irubis–Verve Capital Partners: investment, 202210 seed financing round totalling €2.8m incl co-lead investor Verve Ventures 2022-10-06
Araris Biotech–4BIO Ventures: investment, 202210 financing round totalling $24m incl existing + co-lead investor 4BIO Capital 2022-10-04
Araris Biotech–Bellevue: investment, 202210 financing round totalling $24m incl existing + co-lead investor Pureos Bioventures 2022-10-04
Araris Biotech–btov Partners: investment, 202210 financing round totalling $24m incl existing + co-investor btov Partners 2022-10-04
Araris Biotech–Institute for Follicular Lymphoma Innovation: investment, 202210 financing round totalling $24m incl new + co-investor IFLI 2022-10-04
Araris Biotech–Redalpine: investment, 202210 financing round totalling $24m incl existing + co-investor Redalpine 2022-10-04
Araris Biotech–Schroders: investment, 202210 financing round totalling $24m incl existing + co-investor Schroders Capital 2022-10-04
Araris Biotech–SEVERAL: investment, 202210 financing round $24m co-led by 4BIO Capital + Pureos Bioventures 2022-10-04
Araris Biotech–VI Partners: investment, 202210 financing round totalling $24m incl existing + co-investor VI Partners 2022-10-04
Araris Biotech–Wille Finance: investment, 202210 financing round totalling $24m incl new + co-investor Wille AG 2022-10-04
Sibylla Biotech–Helsinn: investment, 202210 financing round Series A totalling €23m incl co-investor 3B Future Health Fund II S.C.A. SICAV-RAIF 2022-10-04
Sibylla Biotech–SEVERAL: investment, 202210 financing round Series A €23m led by V-Bio Ventures 2022-10-04
Sibylla Biotech–Trophic Communications: public relations, 202210 service existent by Trophic 2022-10-04
Sibylla Biotech–VI Partners: investment, 202210 financing round Series A totalling €23m incl co-investor VI Partners 2022-10-04
Xund Solutions–Lana Ventures: investment, 202209 seed financing round totalling €6m incl co-investor Lana Ventures 2022-09-29
Xund Solutions–MassMutual: investment, 202209 seed financing round totalling €6m incl co-lead investor MassMutual Ventures 2022-09-29
Xund Solutions–MMC Ventures: investment, 202209 seed financing round totalling €6m incl co-lead investor MMC Ventures 2022-09-29
Xund Solutions–Roche: investment, 202209 seed financing round totalling €6m incl co-investor RoX Health 2022-09-29
Xund Solutions–SEVERAL: investment, 202209 seed financing round €6m co-led by MMC Ventures + MassMutual Ventures 2022-09-29
GS Bavaria–High-Tech Gründerfonds: investment, 202209 seed financing round totalling €7-figure incl lead investor HTGF 2022-09-28
GS Bavaria–OTHER: investment, 202209 seed financing round totalling €7-figure incl renowbed business angels 2022-09-28
GS Bavaria–SEVERAL: investment, 202209 seed financing round €7-figure led by HTGF 2022-09-28
Valneva–SEVERAL: investment, 202209–202210 private placement €100-45m of 20.5m ordinary shares at €4.9/share 2022-09-28
Valneva–SEVERAL: investment, 202209–202210 public offering $3.57m of 375k ADSs (each = 2 ordinary shares) at $9.51/ADS 2022-09-28
BioDGraft–NLC Ventures: investment, 202209 existent seed investor NLC 2022-09-27
Kupando–Brandenburg (govt): investment, 202209 financing round Series A totalling €13m incl co-investor Brandenburg Kapital 2022-09-26
Kupando–High-Tech Gründerfonds: investment, 202209 financing round Series A totalling €13m incl co-investor HTGF 2022-09-26
Kupando–LifeCare Partners: investment, 202209 financing round Series A totalling €13m incl co-lead investor LifeCare Partners 2022-09-26
Kupando–OTHER: investment, 202209 financing round Series A totalling €13m incl undisclosed family offices as co-investors 2022-09-26
Kupando–Remiges Ventures: investment, 202209 financing round Series A totalling €13m incl lead investor Remiges Ventures 2022-09-26
Kupando–SEVERAL: investment, 202209 financing round Series A €13m led by Remiges Ventures + co-led by LifeCare Partners 2022-09-26
Kupando–Ventura Biomed Investors: investment, 202209 financing round Series A totalling €13m incl co-investor Venture Biomed Investors 2022-09-26
Evotec–Adapsyn Biotechnology: drug discovery, 202209– strategic collab €na providing Evotec with accesss to drug-like small molecules for screening 2022-09-21
Hedera Dx–Air Street Capital: investment, 202209 seed financing round totalling €14m incl co-investor Air Street Capital 2022-09-21
1 2 3 ... 48 49 50  next pagenext page



Advertisement

Picture [iito] Männer Ballett 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Campus Berlin-Buch GmbH BBC BerlinBioCube Start-up Center 650x300px

» top